Home / Insights Enterprise Newsletter / Insights Newsletter: June 2019

Practice Changing Updates
As cannabidiol (CBD) products move into some pharmacies and retailers, patients will likely have questions about safety, efficacy, and product selection. Pharmacist’s Letter demystifies cannabidiol (CBD) and how it’s regulated, gives safety and efficacy guidance, and offers practical tips to guide patients if they plan to use CBD.
Get Recommendations  >>

New CE Courses
New courses are available for topics including Surgery Suite Medications; STAT! The Pharmacist’s Role in a Code Blue; Integrative Therapies for Depression; Agitation, Sedation, and Delirium in Adult ICU Patients; and more.
View New CE Courses >>